Holen Sie sich die Stockscreener-App
1.60
2.44%
-0.04
Handel nachbörslich:
2.58
0.98
+61.25%
Finanzdaten der Pharmacyte Biotech Inc-Aktie (PMCB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
32.59%
1.8689
|
1.4095 | 2.0753 | 0.9033 | 1.553 |
| Operating Income/Loss |
32.59%
-1.8689
|
-1.4095 | -2.0753 | -0.9033 | -1.553 |
| Nonoperating Income/Loss |
70.25%
1.2494
|
4.1994 | -1.108 | 0.7769 | 0.7888 |
| Income/Loss From Continuing Operations Before Tax |
122.21%
-0.6195
|
2.7899 | -3.1833 | -0.1263 | -0.7641 |
| Income/Loss From Continuing Operations After Tax |
122.21%
-0.6195
|
2.7899 | -3.1833 | -0.1263 | -0.7641 |
|
Net Income/Loss
|
122.21%
-0.6195
|
2.7899 | -3.1833 | -0.1263 | -0.7641 |
| Preferred Stock Dividends And Other Adjustments |
5.0006
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.80%
8.607
|
8.7651 | 12.60 | -0.5624 | 19.00 |
| Diluted Average Shares |
1.80%
8.607
|
8.7651 | 12.60 | -0.5624 | 19.00 |
| Basic Earnings Per Share |
150.00%
-0.65
|
-0.26 | -0.28 | -0.01 | -0.04 |
| Diluted Earnings Per Share |
150.00%
-0.65
|
-0.26 | -0.28 | -0.01 | -0.04 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
5.0006
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):